Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headacheยท2026
Same author

Functional and Patient-Reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study.

Cerebrovascular diseases (Basel, Switzerland)ยท2026
Same author

Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.

Cephalalgia : an international journal of headacheยท2026
Same author

A Response to Mailend et al.: Refined Operational Definitions for the Apraxia of Speech Rating Scale.

American journal of speech-language pathologyยท2026
Same author

Redefining status migrainosus: A narrative review.

Headacheยท2026
Same author

Prospective untreated outcomes in patients with cerebral cavernous malformation.

Journal of neurosurgeryยท2026

Related Experiment Video

Updated: May 10, 2026

A Method for Quantifying Upper Limb Performance in Daily Life Using Accelerometers
07:24

A Method for Quantifying Upper Limb Performance in Daily Life Using Accelerometers

Published on: April 21, 2017

Inability to self-report pain after a stroke: a population-based study.

Jonathan H Smith1, Kari L Bottemiller, Kelly D Flemming

  • 1Department of Neurology, Mayo Clinic, Rochester, MN, USA. smith.jonathan@mayo.edu

Pain
|June 4, 2013
PubMed
Summary

Approximately 13.4% of stroke survivors cannot self-report pain, a rate lower than expected. This inability is linked to stroke severity, aphasia, and consciousness levels, impacting hospitalization outcomes.

More Related Videos

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 10, 2026

A Method for Quantifying Upper Limb Performance in Daily Life Using Accelerometers
07:24

A Method for Quantifying Upper Limb Performance in Daily Life Using Accelerometers

Published on: April 21, 2017

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

Area of Science:

  • Neurology
  • Epidemiology
  • Pain Management

Background:

  • Assessing pain in stroke survivors is crucial for effective management.
  • The frequency of patients unable to self-report pain post-stroke in a population-based sample was previously unquantified.
  • Understanding this limitation is key to accurate pain assessment and care.

Purpose of the Study:

  • To determine the epidemiological frequency of inability to self-report pain in a post-stroke population.
  • To identify factors associated with the inability to self-report pain after stroke.
  • To explore the implications of this inability on hospitalization outcomes.

Main Methods:

  • A population-based cohort study of patients hospitalized after stroke in Olmsted County, Minnesota (June 2008-June 2012).
  • Assessment of pain reporting using the Faces Pain Scale or Numerical Rating Scale upon admission.
  • Statistical analysis to identify associations between inability to self-report pain and stroke severity, aphasia, consciousness, and hospitalization outcomes.

Main Results:

  • Out of 388 patients, 52 (13.4%) were unable to provide a meaningful pain self-report on admission.
  • Inability to self-report pain significantly correlated with stroke severity (P<.0001), aphasia severity (P<.0001), and level of consciousness (P<.0001).
  • This inability was associated with increased risk of in-hospital death (P<.0001) and persistent inability to self-report at dismissal (P<.0001).

Conclusions:

  • The frequency of inability to self-report pain post-stroke is lower than previously assumed.
  • Stroke severity, aphasia, and impaired consciousness are key predictors of pain self-reporting difficulties.
  • Future research on observational pain scales should prioritize stroke patients with aphasia and altered consciousness.